PAS
SMTI icon

Point72 Asia (Singapore)’s Sanara MedTech SMTI Stock Holding History

Point72 Asia (Singapore)’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11.6K Buy
+365
New +$11K ﹤0.01% 768

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Point72 Asia (Singapore)'s SMTI Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Sanara MedTech (SMTI) in Q3 2025: 365 shares worth $11.6K. The stake represents ﹤0.01% of the portfolio and ranks #768 among its holdings.

58 funds tracked by Wall St. Rank hold SMTI as of Q3 2025.

  • Point72 Asia (Singapore) held 365 shares of Sanara MedTech worth $11.6K as of Q3 2025.
  • Sanara MedTech was a new Point72 Asia (Singapore) position in Q3 2025.
  • Sanara MedTech made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #768 holding.
  • 58 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.